Klotrimazolas Polpharm

Clotrimazole, the active ingredient in Klotrimazolas Polpharm, is an imidazole antifungal presented as a topical formulation for cutaneous use. It treats superficial fungal infections such as athlete’s foot, ringworm and cutaneous yeast infections in adults and children.

GNH USA supplies Klotrimazolas Polpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clotrimazole is used to treat fungal skin infections by targeting the dermatophyte and yeast pathogens that cause these conditions.

Tinea corporis: clears ring‑shaped lesions on the body. Tinea pedis: relieves itching and scaling of athlete’s foot. Candidiasis: eliminates cutaneous yeast infections. Dermatophytosis: eradicates skin fungal spread.

Clotrimazole may cause local skin reactions, most of which are mild and reversible.

Common Side Effects: - Skin irritation: redness or itching at the application site. - Burning sensation: mild transient burning after application. - Itching: localized pruritus. - Dryness: localized skin dryness.

Serious or Rare Side Effects: - Contact dermatitis: allergic reaction with swelling and rash. - Stevens‑Johnson syndrome: rare severe skin reaction. - Angioedema: swelling of deeper skin layers.

When using Klotrimazolas Polpharm, follow these safety measures.

- Application area: apply a thin layer to clean, dry skin. - Duration: limit use to the period recommended by a healthcare professional. - Avoid eyes: keep the product away from eyes and mucous membranes. - Use in children: consult a healthcare professional before use in pediatric patients. - Pregnancy and lactation: discuss with a physician before use. - Store at room temperature: keep in the original container, protect from moisture and light.

Clotrimazole may interact with other topical or systemic agents; consider the following.

Major Interactions (Avoid): - Concurrent use with other topical azole antifungals may increase local irritation. - Use with systemic antifungal agents metabolized by CYP450 may alter plasma levels, although topical absorption is minimal. - Co‑application with corticosteroids may reduce antifungal efficacy.

Moderate Interactions (Monitor Closely): - Use with occlusive dressings may enhance absorption. - Combination with other skin irritants (e.g., retinoids) may increase local reactions. - Use with alcohol‑based cleansers may affect drug stability.